1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Competitor Analysis: Human Growth Hormone (hGH)

Competitor Analysis: Human Growth Hormone (hGH)

  • April 2013
  • -
  • La Merie Publishing
  • -
  • 49 pages

Product description

The Competitive Intelligence Report Human Growth Hormone (hGH) as of April 2013 provides a competitor analysis in the development pipeline of biosimilar versions of somatropin and next generation biobetter/biosuperior hGH products for treatment of growth hormone deficiency (GHD) in childrens and adults and related diseases. 2012 global sales data of branded hGH products in regulated marktes are provided. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently marketed hGH products and active projects in research and development of novel hGH products. In addition, the report lists company-specific R&D pipelines of hGH products and projects Competitor projects are listed in a tabular format providing Information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Territory,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table Of Contents

Competitor Analysis: Human Growth Hormone (hGH)
Table of Contents

• 2012 Sales of Branded Somatropin Products in Regulated Markets
• 2012 Sales of Selected Somatropin Products in Non-Regulated Markets
• 1st Generation: Somatropin in Regulated Markets
• 1st Generation: Biosimilar Somatropin in Regulated Markets
• 2nd Generation: Injectable Somatropin in Slow-release Formulation in Regulated Markets
• 2nd Generation: Injectable Long-acting Somatropin in Regulated Markets
• 2nd Generation: Injection-Free Somatropin in Regulated Markets
• 1st Generation: Somatropin Products in Non-Regulated Markets
• 2nd Generation: Injectable Long-Acting Somatropin Products in Non-Regulated Markets
• Non-Medical, Legal Uses of Somatropin
• Corporate hGH RandD Pipelines

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • December 2016
  • by GlobalData

Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Growth Hormone Deficiency Global Clinical Trials Review, H2, 2016" provides an overview ...

Global Human Growth Hormone Drugs - Pharmaceuticals

Global Human Growth Hormone Drugs - Pharmaceuticals

  • $ 4950
  • Industry report
  • January 2017
  • by Global Industry Analysts

This report analyzes the worldwide markets for Human Growth Hormone Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest ...

Global Biopharmaceutical Market Report & Forecast (2016-2021)

Global Biopharmaceutical Market Report & Forecast (2016-2021)

  • $ 1500
  • Industry report
  • July 2016
  • by International Market Analysis Research and Consult

The global biopharmaceutical Industry has come a long way since its first drug- Humulin was approved in 1982. Today hundreds of biopharmaceuticals have already been approved and many more are in late stages ...


ref:plp2013

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.